ozone has been researched along with pyrazolanthrone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adcock, IM; Bennett, BL; Chung, KF; Ferguson, GD; Issa, R; Leung, SY; Nath, P; Williams, AS | 1 |
| Chauvin, MA; Croze, ML; Géloën, A; Guichardant, M; Koppe, L; Pesenti, S; Pillon, NJ; Rieusset, J; Soulage, CO; Vella, RE; Zarrouki, B | 1 |
2 other study(ies) available for ozone and pyrazolanthrone
| Article | Year |
|---|---|
Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-Jun NH2 terminal kinase inhibitor SP600125.
Topics: Animals; Anthracenes; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Gene Expression Regulation; Inflammation; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lung; Male; Mice; Mice, Inbred BALB C; Oligonucleotide Array Sequence Analysis; Ozone; Phosphorylation; Polymerase Chain Reaction; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-jun | 2007 |
Ozone exposure triggers insulin resistance through muscle c-Jun N-terminal kinase activation.
Topics: Acetylcysteine; Animals; Anthracenes; Bronchoalveolar Lavage Fluid; Cell Line; Enzyme Activation; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Mice; Ozone; Phenylbutyrates; Rats | 2015 |